Literature DB >> 16450883

Antimicrobial peptide resistance mechanisms of human bacterial pathogens.

Victor Nizet1.   

Abstract

The critical role played by antimicrobial peptides (AMPs) in mammalian innate immunity is increasingly recognized. Bacteria differ in their intrinsic susceptibility to AMPs, and the relative resistance of some important human pathogens to these defense molecules is now appreciated as an important virulence phenotype. Experimental analysis has identified diverse mechanisms of bacterial AMP resistance including altered cell surface charge, active efflux, production of proteases or trapping proteins, and modification of host cellular processes. The contribution of these resistance mechanisms to pathogenesis is confirmed through direct comparison of wild-type bacteria and AMP-sensitive mutants using in vivo infection models. Knowledge of the molecular basis of bacterial AMP resistance may provide new targets for antimicrobial therapy of human infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16450883

Source DB:  PubMed          Journal:  Curr Issues Mol Biol        ISSN: 1467-3037            Impact factor:   2.081


  110 in total

Review 1.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

2.  Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile.

Authors:  Shonna M McBride; Abraham L Sonenshein
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Innate barriers against infection and associated disorders.

Authors:  Richard L Gallo; Victor Nizet
Journal:  Drug Discov Today Dis Mech       Date:  2008-06-01

4.  Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37.

Authors:  Adam A Strömstedt; Mukesh Pasupuleti; Artur Schmidtchen; Martin Malmsten
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

5.  Boosting antimicrobial peptides by hydrophobic oligopeptide end tags.

Authors:  Artur Schmidtchen; Mukesh Pasupuleti; Matthias Mörgelin; Mina Davoudi; Jan Alenfall; Anna Chalupka; Martin Malmsten
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

6.  Structure-function studies of Bubalus bubalis lingual antimicrobial peptide analogs.

Authors:  Dhruba Jyoti Kalita; Ashok Kumar; Satish Kumar
Journal:  Vet Res Commun       Date:  2008-07-24       Impact factor: 2.459

Review 7.  On the physiology and pathophysiology of antimicrobial peptides.

Authors:  Roland Pálffy; Roman Gardlík; Michal Behuliak; Ludevit Kadasi; Jan Turna; Peter Celec
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

8.  Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides.

Authors:  Enrique Llobet; Catalina March; Paloma Giménez; José A Bengoechea
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

9.  Topical delivery of low-cost protein drug candidates made in chloroplasts for biofilm disruption and uptake by oral epithelial cells.

Authors:  Yuan Liu; Aditya C Kamesh; Yuhong Xiao; Victor Sun; Michael Hayes; Henry Daniell; Hyun Koo
Journal:  Biomaterials       Date:  2016-08-02       Impact factor: 12.479

10.  Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16.

Authors:  Bruk Mensa; Gabriella L Howell; Richard Scott; William F DeGrado
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.